Laboratorios Farmaceuticos Rovi, S.A. Share Price Wiener Boerse
Stocks
ROVI
ES0157261019
Pharmaceuticals
OTC Markets Traded|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 59.32 EUR | -1.04% |
|
+6.39% | -5.29% |
| 07-23 | Laboratorios Farmaceuticos Rovi, S.A., H1 2026 Earnings Call, Jul 23, 2026 | |
| 07-23 | Laboratorios Farmaceuticos Rovi, S.A. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| Market Cap | 3.05B 3.51B 2.83B 2.61B 4.91B 335B 5B 33.48B 13.11B 166B 13.17B 12.88B 559B | P/E 2026 * |
21.3x | P/E 2027 * | 17.6x |
|---|---|---|---|---|---|
| Enterprise Value | 3.03B 3.49B 2.81B 2.59B 4.89B 333B 4.98B 33.3B 13.04B 165B 13.1B 12.81B 556B | EV / Sales 2026 * |
3.93x | EV / Sales 2027 * | 3.33x |
| Free-Float |
31.63% | Yield 2026 * |
1.62% | Yield 2027 * | 1.96% |
Last Transcript: Laboratorios Farmaceuticos Rovi, S.A.
| 1 day | -1.08% | ||
| 1 week | +6.39% | ||
| Current month | +3.54% | ||
| 1 month | +2.13% | ||
| 3 months | -24.07% | ||
| 6 months | -17.65% | ||
| Current year | -5.29% |
| 1 week | 58.2 |  | 59.95 |
| 1 month | 53.15 | | 59.95 |
| Current year | 53.15 | | 86.6 |
| 1 year | 51.85 | | 86.6 |
| 3 years | 43.8 | | 90.75 |
| 5 years | 35.64 | | 90.75 |
| 10 years | 35.64 | | 90.75 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 26/07/2007 | |
| Director of Finance/CFO | - | 31/12/2000 | |
| Chief Operating Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | 16/07/2021 | |
| Director/Board Member | - | 26/07/2007 | |
| Director/Board Member | - | 26/07/2007 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.04% | +6.39% | - | - | 3.47B | |
| -3.97% | -2.08% | +52.77% | +155.45% | 1,079B | |
| -3.80% | -1.40% | +52.84% | +52.60% | 640B | |
| -1.72% | +0.71% | +36.68% | +72.98% | 465B | |
| -2.29% | +1.12% | +36.13% | +30.60% | 353B | |
| -2.28% | -0.69% | +33.42% | +39.21% | 301B | |
| -3.15% | +0.25% | +10.63% | +13.71% | 271B | |
| -2.12% | +3.31% | +1.82% | -39.41% | 228B | |
| -0.75% | +3.69% | +27.82% | +64.52% | 209B | |
| -2.07% | -0.66% | +13.28% | +70.74% | 165B | |
| Average | -2.34% | +4.83% | +29.49% | +51.16% | 412.19B | |
| Weighted average by Cap. | -2.94% | +4.86% | +38.25% | +74.89% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 772M 888M 717M 661M 1.24B 84.82B 1.27B 8.48B 3.32B 42.12B 3.34B 3.26B 142B | 891M 1.03B 827M 763M 1.44B 97.91B 1.46B 9.79B 3.83B 48.63B 3.85B 3.77B 164B |
| Net income | 129M 148M 119M 110M 207M 14.13B 211M 1.41B 553M 7.02B 556M 544M 23.6B | 174M 200M 161M 149M 281M 19.11B 286M 1.91B 748M 9.49B 752M 735M 31.92B |
| Net Debt | -16.21M -18.67M -15.06M -13.89M -26.16M -1.78B -26.63M -178M -69.79M -885M -70.1M -68.56M -2.98B | -81.51M -93.84M -75.69M -69.8M -131M -8.96B -134M -896M -351M -4.45B -352M -345M -14.96B |
| Date | Price | Change |
|---|---|---|
| 28/07/26 | €59.95 | +1.01% |
| 28/07/26 | €59.35 | -0.17% |
| 27/07/26 | €59.45 | +0.59% |
| 24/07/26 | €59.10 | +0.68% |
| 23/07/26 | €58.70 | +4.17% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ROVI Stock
- ROVI Stock
Select your edition
All financial news and data tailored to specific country editions
